Single-Agent Topotecan as First-Line Chemotherapy in Women with Metastatic Breast Cancer: Final Results of Eastern Cooperative Oncology Group Trial E8193

Single Agent ◽

Metastatic Breast ◽

Oncology Group ◽

First Line ◽

Group Trial ◽

Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80197-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S66-S67

Author(s):

B Ejlertsen

Keyword(s):

Breast Cancer ◽

Single Agent ◽

Metastatic Breast ◽

First Line ◽

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients

Breast Cancer Research and Treatment ◽

10.1023/a:1006394801389 ◽

2000 ◽

Vol 59 (2) ◽

pp. 133-139 ◽

Cited By ~ 21

Author(s):

Andrea Michelotti ◽

Marco Venturini ◽

Carmelo Tibaldi ◽

Carmelo Bengala ◽

Luigi Gallo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial)

European Journal of Cancer ◽

10.1016/s0959-8049(16)30807-3 ◽

2015 ◽

Vol 51 ◽

pp. S284

Author(s):

G.G. Steger ◽

A. Dominguez ◽

N. Dobrovolskaya ◽

F. Giotta ◽

N. Tubiana-Mathieu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Oral Vinorelbine ◽

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-009-0658-9 ◽

2009 ◽

Vol 119 (3) ◽

pp. 663-671 ◽

Cited By ~ 30

Author(s):

Stacy Moulder ◽

Hailun Li ◽

Molin Wang ◽

William J. Gradishar ◽

Edith A. Perez ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Oncology Group ◽

Her2 Positive ◽

275 ORAL First-line bevacizumab and paclitaxel in patients with locally recurrent or metastatic breast cancer: a randomized, phase III trial coordinated by the Eastern Cooperative Oncology Group (E2100)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)80573-7 ◽

2005 ◽

Vol 3 (2) ◽

pp. 77-78 ◽

Cited By ~ 6

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Oncology Group ◽

First Line ◽

Phase Iii Trial ◽

Locally Recurrent

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-0838-7 ◽

2010 ◽

Vol 121 (1) ◽

pp. 111-120 ◽

Cited By ~ 20

Author(s):

Antonio C. Wolff ◽

Molin Wang ◽

Hailun Li ◽

Michael R. Pins ◽

Florence J. Pretorius ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin ◽

Oncology Group ◽

Phase III trial of doxorubicin (A)/cyclophosphamide (C) (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer (MBC): Japan Clinical Oncology Group trial (JCOG9802)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.521 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 521-521 ◽

Cited By ~ 6

Author(s):

N. Katsumata ◽

H. Minami ◽

K. Aogi ◽

T. Tabei ◽

M. Sano ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Oncology Group ◽

Front Line ◽

Japan Clinical Oncology Group ◽

Phase Iii Trial ◽

Group Trial ◽

Plasma Matrix Metalloproteinases 7 and 9 in Patients with Metastatic Breast Cancer Treated with Marimastat or Placebo: Eastern Cooperative Oncology Group Trial E2196

Clinical Breast Cancer ◽

10.3816/cbc.2006.n.006 ◽

2006 ◽

Vol 6 (6) ◽

pp. 525-529 ◽

Cited By ~ 4

Author(s):

Stanley Zucker ◽

Molin Wang ◽

Joseph A. Sparano ◽

William J. Gradishar ◽

James N. Ingle ◽

...

Keyword(s):

Breast Cancer ◽

Matrix Metalloproteinases ◽

Metastatic Breast ◽

Oncology Group ◽

Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(05)80313-3 ◽

2006 ◽

Vol 16 (4) ◽

pp. 378

Author(s):

A.D. Seidman

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Phase Iii ◽

Oncology Group ◽

First Line ◽

Phase Iii Trial ◽

Central European ◽

International Multicenter ◽

Comparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trial

Cancer ◽

10.1002/1097-0142(19821001)50:7<1235::aid-cncr2820500703>3.0.co;2-l ◽

1982 ◽

Vol 50 (7) ◽

pp. 1235-1244 ◽

Cited By ~ 78

Author(s):

Douglass C. Tormey ◽

Rebecca Gelman ◽

Pierre R. Band ◽

Mary Sears ◽

Susan N. Rosenthal ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast ◽

Oncology Group ◽